Novo Nordisk on Jan.1 will implement a policy to let 340B hospitals buy its drugs at a reduced 340B price for shipment to an unlimited number of contract pharmacies if the hospitals submit their claims data for such drugs to drug industry contractor 340B ESP.
Hospitals reported getting email messages from Novo Nordisk on Saturday with an attached letter announcing the change. 340B ESP posted Novo Nordisk’s new policy on its website late yesterday. It said its platform will not be configured to support Novo Nordisk-related claims data submissions, contract pharmacy designations, or wholly owned contract pharmacy exemptions until Jan. 1.
Novo Nordisk on Jan.1 will implement a policy to let 340B hospitals buy its drugs at a reduced 340B price for shipment to an unlimited number of contract pharmacies if the hospitals submit their claims data for such drugs to drug industry contractor 340B ESP.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
